QQQ   312.83 (-3.49%)
AAPL   120.99 (-3.48%)
MSFT   228.99 (-2.37%)
FB   254.69 (-3.64%)
GOOGL   2,015.95 (-3.26%)
AMZN   3,057.16 (-3.24%)
TSLA   682.22 (-8.06%)
NVDA   532.30 (-8.22%)
BABA   240.18 (-4.06%)
CGC   33.21 (-6.71%)
GE   12.76 (-2.74%)
MU   88.12 (-4.76%)
NIO   46.81 (-9.74%)
AMD   82.42 (-5.20%)
T   28.63 (-2.55%)
F   11.76 (-4.16%)
ACB   10.82 (-7.04%)
DIS   190.98 (-3.31%)
BA   216.45 (-5.62%)
NFLX   546.70 (-1.21%)
BAC   35.93 (-1.24%)
QQQ   312.83 (-3.49%)
AAPL   120.99 (-3.48%)
MSFT   228.99 (-2.37%)
FB   254.69 (-3.64%)
GOOGL   2,015.95 (-3.26%)
AMZN   3,057.16 (-3.24%)
TSLA   682.22 (-8.06%)
NVDA   532.30 (-8.22%)
BABA   240.18 (-4.06%)
CGC   33.21 (-6.71%)
GE   12.76 (-2.74%)
MU   88.12 (-4.76%)
NIO   46.81 (-9.74%)
AMD   82.42 (-5.20%)
T   28.63 (-2.55%)
F   11.76 (-4.16%)
ACB   10.82 (-7.04%)
DIS   190.98 (-3.31%)
BA   216.45 (-5.62%)
NFLX   546.70 (-1.21%)
BAC   35.93 (-1.24%)
QQQ   312.83 (-3.49%)
AAPL   120.99 (-3.48%)
MSFT   228.99 (-2.37%)
FB   254.69 (-3.64%)
GOOGL   2,015.95 (-3.26%)
AMZN   3,057.16 (-3.24%)
TSLA   682.22 (-8.06%)
NVDA   532.30 (-8.22%)
BABA   240.18 (-4.06%)
CGC   33.21 (-6.71%)
GE   12.76 (-2.74%)
MU   88.12 (-4.76%)
NIO   46.81 (-9.74%)
AMD   82.42 (-5.20%)
T   28.63 (-2.55%)
F   11.76 (-4.16%)
ACB   10.82 (-7.04%)
DIS   190.98 (-3.31%)
BA   216.45 (-5.62%)
NFLX   546.70 (-1.21%)
BAC   35.93 (-1.24%)
QQQ   312.83 (-3.49%)
AAPL   120.99 (-3.48%)
MSFT   228.99 (-2.37%)
FB   254.69 (-3.64%)
GOOGL   2,015.95 (-3.26%)
AMZN   3,057.16 (-3.24%)
TSLA   682.22 (-8.06%)
NVDA   532.30 (-8.22%)
BABA   240.18 (-4.06%)
CGC   33.21 (-6.71%)
GE   12.76 (-2.74%)
MU   88.12 (-4.76%)
NIO   46.81 (-9.74%)
AMD   82.42 (-5.20%)
T   28.63 (-2.55%)
F   11.76 (-4.16%)
ACB   10.82 (-7.04%)
DIS   190.98 (-3.31%)
BA   216.45 (-5.62%)
NFLX   546.70 (-1.21%)
BAC   35.93 (-1.24%)
Log in
NASDAQ:TFFP

TFF Pharmaceuticals Stock Forecast, Price & News

$14.45
-0.75 (-4.93 %)
(As of 02/25/2021 12:00 AM ET)
Add
Compare
Today's Range
$14.29
Now: $14.45
$15.42
50-Day Range
$15.20
MA: $17.29
$19.75
52-Week Range
$3.44
Now: $14.45
$21.14
Volume368,725 shs
Average Volume372,607 shs
Market Capitalization$321.17 million
P/E RatioN/A
Dividend YieldN/A
Beta2.47
TFF Pharmaceuticals, Inc., an early-stage biopharmaceutical company, focuses on developing and commercializing drug products based on its patented Thin Film Freezing, or TFF, technology platform. It intends to initially focus on the development of inhaled dry powder drugs for the treatment of pulmonary diseases and conditions. The company has a research collaboration with the University of Georgia's Center for Vaccines and Immunology (CVI), along with the University of Texas at Austin (UT Austin), to evaluate the immunogenicity of universal influenza vaccines; and cooperative research and development agreement with United States Army Medical Research Institute of Infectious Diseases for use of its thin film freezing technology platform. TFF Pharmaceuticals, Inc. also has a joint development and collaboration agreement with Augmenta Bioworks, Inc. to develop commercial products incorporating Augmenta's human-derived monoclonal antibodies for COVID-19 therapeutics. The company was founded in 2018 and is based in Austin, Texas.

Headlines

TFF Pharmaceuticals EPS misses by $0.05
November 5, 2020 |  seekingalpha.com
See More Headlines

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:TFFP
CUSIPN/A
CIKN/A
Phone737-802-1973
Employees4
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Book Value$1.50 per share

Profitability

Net Income$-11,870,000.00

Miscellaneous

Market Cap$321.17 million
Next Earnings Date3/10/2021 (Confirmed)
OptionableNot Optionable

MarketRank

Overall MarketRank

1.39 out of 5 stars

Medical Sector

567th out of 1,957 stocks

Pharmaceutical Preparations Industry

285th out of 771 stocks

Analyst Opinion: 3.5Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -
$14.45
-0.75 (-4.93 %)
(As of 02/25/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive TFFP News and Ratings via Email

Sign-up to receive the latest news and ratings for TFFP and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











TFF Pharmaceuticals (NASDAQ:TFFP) Frequently Asked Questions

Is TFF Pharmaceuticals a buy right now?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for TFF Pharmaceuticals in the last year. There are currently 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" TFF Pharmaceuticals stock.
View analyst ratings for TFF Pharmaceuticals
or view top-rated stocks.

What stocks does MarketBeat like better than TFF Pharmaceuticals?

Wall Street analysts have given TFF Pharmaceuticals a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but TFF Pharmaceuticals wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting TFF Pharmaceuticals?

TFF Pharmaceuticals saw a decrease in short interest in the month of January. As of January 29th, there was short interest totaling 307,000 shares, a decrease of 59.7% from the January 14th total of 761,200 shares. Based on an average trading volume of 316,200 shares, the short-interest ratio is presently 1.0 days. Currently, 1.7% of the company's stock are short sold.
View TFF Pharmaceuticals' Short Interest
.

When is TFF Pharmaceuticals' next earnings date?

TFF Pharmaceuticals is scheduled to release its next quarterly earnings announcement on Wednesday, March 10th 2021.
View our earnings forecast for TFF Pharmaceuticals
.

How can I listen to TFF Pharmaceuticals' earnings call?

TFF Pharmaceuticals will be holding an earnings conference call on Wednesday, March 10th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were TFF Pharmaceuticals' earnings last quarter?

TFF Pharmaceuticals, Inc. (NASDAQ:TFFP) posted its quarterly earnings results on Thursday, November, 5th. The company reported ($0.24) EPS for the quarter, missing the consensus estimate of ($0.19) by $0.05.
View TFF Pharmaceuticals' earnings history
.

How has TFF Pharmaceuticals' stock been impacted by COVID-19 (Coronavirus)?

TFF Pharmaceuticals' stock was trading at $4.00 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, TFFP stock has increased by 261.3% and is now trading at $14.45.
View which stocks have been most impacted by COVID-19
.

What price target have analysts set for TFFP?

4 equities research analysts have issued twelve-month target prices for TFF Pharmaceuticals' shares. Their forecasts range from $18.00 to $36.00. On average, they expect TFF Pharmaceuticals' stock price to reach $27.00 in the next twelve months. This suggests a possible upside of 86.9% from the stock's current price.
View analysts' price targets for TFF Pharmaceuticals
or view top-rated stocks among Wall Street analysts.

Who are TFF Pharmaceuticals' key executives?

TFF Pharmaceuticals' management team includes the following people:
  • Mr. Glenn R. Mattes, Pres, CEO & Director (Age 66, Pay $516.67k)
  • Mr. Kirk Allen Coleman, CFO, Treasurer & Sec. (Age 49, Pay $281.91k)
  • Dr. James Brian Windsor, Chief Science Officer & Director (Age 55, Pay $150k)
  • Mr. Christopher Cano, COO & VP of Bus. Devel.

Who are some of TFF Pharmaceuticals' key competitors?

What other stocks do shareholders of TFF Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other TFF Pharmaceuticals investors own include Fulcrum Therapeutics (FULC), VBI Vaccines (VBIV), Akero Therapeutics (AKRO), VYNE Therapeutics (VYNE), Acer Therapeutics (ACER), Aldeyra Therapeutics (ALDX), AVEO Pharmaceuticals (AVEO), Chiasma (CHMA), Chimerix (CMRX) and DURECT (DRRX).

When did TFF Pharmaceuticals IPO?

(TFFP) raised $22 million in an IPO on Friday, October 25th 2019. The company issued 4,400,000 shares at a price of $5.00 per share. National Securities acted as the underwriter for the IPO.

What is TFF Pharmaceuticals' stock symbol?

TFF Pharmaceuticals trades on the NASDAQ under the ticker symbol "TFFP."

Who are TFF Pharmaceuticals' major shareholders?

TFF Pharmaceuticals' stock is owned by a number of retail and institutional investors. Top institutional investors include BlackRock Inc. (1.26%), Precept Management LLC (0.67%), Janney Montgomery Scott LLC (0.24%), ExodusPoint Capital Management LP (0.22%), Renaissance Technologies LLC (0.16%) and First Trust Advisors LP (0.13%). Company insiders that own TFF Pharmaceuticals stock include Aaron GL Fletcher, Glenn R Mattes, Harlan F Weisman, James Brian Windsor, Kirk Allen Coleman, Lung Therapeutics, Inc, Malcolm Fairbairn, Randy H Thurman and Robert S Mills.
View institutional ownership trends for TFF Pharmaceuticals
.

Which major investors are selling TFF Pharmaceuticals stock?

TFFP stock was sold by a variety of institutional investors in the last quarter, including Precept Management LLC, Renaissance Technologies LLC, Mesirow Financial Investment Management Inc., and First Trust Advisors LP. Company insiders that have sold TFF Pharmaceuticals company stock in the last year include Glenn R Mattes, James Brian Windsor, Kirk Allen Coleman, Lung Therapeutics, Inc, Malcolm Fairbairn, Randy H Thurman, and Robert S Mills.
View insider buying and selling activity for TFF Pharmaceuticals
or view top insider-selling stocks.

Which major investors are buying TFF Pharmaceuticals stock?

TFFP stock was bought by a variety of institutional investors in the last quarter, including Janney Montgomery Scott LLC, ExodusPoint Capital Management LP, BlackRock Inc., Citigroup Inc., Wells Fargo & Company MN, Baldwin Brothers Inc. MA, Venturi Wealth Management LLC, and Advisory Services Network LLC. Company insiders that have bought TFF Pharmaceuticals stock in the last two years include Aaron GL Fletcher, Glenn R Mattes, Harlan F Weisman, and Kirk Allen Coleman.
View insider buying and selling activity for TFF Pharmaceuticals
or or view top insider-buying stocks.

How do I buy shares of TFF Pharmaceuticals?

Shares of TFFP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is TFF Pharmaceuticals' stock price today?

One share of TFFP stock can currently be purchased for approximately $14.45.

How much money does TFF Pharmaceuticals make?

TFF Pharmaceuticals has a market capitalization of $321.17 million. The company earns $-11,870,000.00 in net income (profit) each year or ($5.31) on an earnings per share basis.

How many employees does TFF Pharmaceuticals have?

TFF Pharmaceuticals employs 4 workers across the globe.

What is TFF Pharmaceuticals' official website?

The official website for TFF Pharmaceuticals is www.tffpharma.com.

Where are TFF Pharmaceuticals' headquarters?

TFF Pharmaceuticals is headquartered at 2600 Via Fortuna Suite 360, Austin TX, 78746.

How can I contact TFF Pharmaceuticals?

TFF Pharmaceuticals' mailing address is 2600 Via Fortuna Suite 360, Austin TX, 78746. The company can be reached via phone at 737-802-1973 or via email at [email protected]


This page was last updated on 2/25/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.